
The Europe-Africa Oncology Alliance
Building a shared ecosystem for oncology research, training, and patient-centered care between Europe and Africa.

The Europe-Africa Oncology Alliance
Building a shared ecosystem for oncology research, training, and patient-centered care between Europe and Africa.
The Europe–Africa Oncology Alliance is an international cooperation platform dedicated to advancing cancer research, education, and patient-centered care across continents.
It was developed by ISHEO, building on the success and methodology of its flagship initiative, BRIDGE THE GAP, a multistakeholder program launched in Italy in 2022 that connects clinicians, patient associations, healthcare managers, industry leaders, and institutions to overcome barriers in oncology care and clinical research.
Thanks to this experience, ISHEO now extends that proven collaborative model to a broader international scale, turning shared expertise into a bridge between continents.
The Alliance aims to strengthen cooperation among research centers and hospitals, patient associations and advocacy groups, CROs and CDMOs, laboratories, investors, pharmaceutical and biotech companies, regulators, educators, and healthcare managers throughout Europe and Africa.
Its overarching goal is to build a shared ecosystem of innovation and equity in oncology—fostering dialogue, capacity building, and joint action to improve outcomes for patients affected by non-communicable diseases (NCDs), with a particular focus on oncological, onco-hematological, and rare diseases.
The Europe–Africa Oncology Alliance provides a framework for collaboration through:
Through education and awareness campaigns, the promotion of pharmaceutical and biotechnological innovation, and the evaluation of their impact on health outcomes, the Alliance seeks to advance access to care, improve patient journeys, and enhance quality of life across diverse healthcare systems.
Acting as both a knowledge hub and a collaborative engine, the Europe–Africa Oncology Alliance translates cooperation into new, patient-centered models of care adapted to local contexts.
It embodies ISHEO’s long-standing commitment to dialogue, innovation, and sustainability in health systems– transforming collaboration into impact and building a stronger, more connected oncology ecosystem for the future.

A network for excellence in clinical research training, linking European, Middle East and African centers to share competencies, standards, and methodologies.
Learning programs can be tailored following a comprehensive training needs assessment, conducted through interviews and discussions with prospective participants and institutional partners.
This process allows the identification of specific learning priorities, skills gaps, and operational contexts relevant to each organization or research team.
Based on these findings, the final training program is then structured and delivered by selecting and adapting the most relevant modules from the core curriculum, ensuring that the content is directly aligned with participants professional objectives and the strategic goals of their working team. professionals such as Clinical Research Associates, Clinical Project Managers, Data Managers, and Clinical Research Coordinators, as well as programs on Good Clinical Practice (GCP) and clinical study design.
European regulatory architecture: EU Regulation 536/2014, the role of EMA and CTIS, and alignment with the African Medicines Agency (AMA).
Objective: to transfer competencies needed to conduct studies compliant with EU standards.
Practical application of the new Good Clinical Practice guidelines, focusing on Quality by Design, risk management, and patient centrality.
Objective: to ensure compliance with the most recent international standards
Procedures for study initiation, feasibility assessment, investigator selection, ethics submission, and management of multicenter research sites.
Objective: to build operational capabilities for transnational clinical trials.
Use of eCRF, EDC, and eTMF systems compliant with GxP and GDPR within the EU framework.
Objective: to ensure quality, traceability, and data security in clinical studies.
System audits, CAPA management, vendor oversight, and preparation for EMA/FDA inspections.
Objective: to strengthen the culture of quality within research centers.
Planning, risk management, monitoring, and reporting for multicenter studies.
Objective: to train coordination roles such as Clinical Project Managers and Operations Leads.
On-site and centralized monitoring techniques aligned with GCP E6(R3).
Objective: to optimize quality control in decentralized or resource-limited studies.
Documentation management in compliance with ALCOA+ standards, archiving, and audit readiness.
Objective: to maintain compliance and traceability throughout the study lifecycle.
A modern approach to risk management and quality planning.
Objective: to increase efficiency and data robustness.
Informed consent processes, community engagement, and respect for local contexts.
Objective: to promote ethical and culturally sensitive clinical research.
Protection of personal data and cybersecurity in international trials.
Objective: to harmonize data-privacy practices between the EU, Middle East and Africa.
Specific training for Principal Investigators, Sub-Investigators, and site coordinators, including case studies and simulations.
Objective: to standardize trial management and improve site performance.
These training programs serve as a practical bridge between the European, Middle East and African regulatory and research ecosystems, promoting:
The training courses are designed for:
The network draws on the expertise of CRES Academy, which since 2015 has been designing and delivering tailored courses for research centers and professionals such as Clinical Research Associates, Clinical Project Managers, Data Managers, and Clinical Research Coordinators, as well as programs on Good Clinical Practice (GCP) and clinical study design.
A pan-African summit on oncology and non-communicable diseases (NCDs) bringing together healthcare professionals, policymakers, patient advocates, researchers, and industry leaders from across the continent and beyond.
The Summit is designed to:
The overarching goal of the Africa Oncology Summit is to accelerate equitable access to therapies and to strengthen health system capacity for the management of non-communicable diseases — starting with hematologic and oncologic conditions.
By creating a platform for dialogue, knowledge exchange, and coordinated action, the Summit aims to inspire a new generation of partnerships that translate research excellence into improved patient outcomes and quality of life across the African continent.
Join the Alliance. Shape the future of global oncology.
Would you like to learn more, partner with the Alliance, or explore joint initiatives?
Contact us to start building new bridges between Europe and Africa — in research, education, and care.